These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 15320482)

  • 21. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility.
    Ferreirós-Vidal I; Barros F; Pablos JL; Carracedo A; Gómez-Reino JJ; Gonzalez A
    Rheumatology (Oxford); 2003 Nov; 42(11):1380-2. PubMed ID: 12810925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population.
    Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A
    Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease.
    Yamazaki K; Takazoe M; Tanaka T; Kazumori T; Nakamura Y
    J Hum Genet; 2002; 47(9):469-72. PubMed ID: 12202985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
    Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.
    Chua KH; Hilmi I; Ng CC; Eng TL; Palaniappan S; Lee WS; Goh KL
    J Dig Dis; 2009 May; 10(2):124-30. PubMed ID: 19426395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
    Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.
    Jess T; Riis L; Jespersgaard C; Hougs L; Andersen PS; Orholm MK; Binder V; Munkholm P
    Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute intestinal obstruction and NOD2/CARD15 mutations among Italian Crohn's disease patients.
    Guagnozzi D; Cossu A; Viscido A; Corleto V; Annese V; Latiano A; Delle Fave G; Caprilli R
    Eur Rev Med Pharmacol Sci; 2004; 8(5):179-85. PubMed ID: 15638227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
    Laukens D; Peeters H; Marichal D; Vander Cruyssen B; Mielants H; Elewaut D; Demetter P; Cuvelier C; Van Den Berghe M; Rottiers P; Veys EM; Remaut E; Steidler L; De Keyser F; De Vos M
    Ann Rheum Dis; 2005 Jun; 64(6):930-5. PubMed ID: 15539413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CARD15 gene and the classification of Crohn's disease.
    Murillo L; Crusius JB; van Bodegraven AA; Alizadeh BZ; Peña AS
    Immunogenetics; 2002 Apr; 54(1):59-61. PubMed ID: 11976792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs.
    Hradsky O; Lenicek M; Dusatkova P; Bronsky J; Nevoral J; Valtrova V; Kotalova R; Szitanyi P; Petro R; Starzykova V; Bortlik M; Vitek L; Lukas M; Cinek O
    Tissue Antigens; 2008 Jun; 71(6):538-47. PubMed ID: 18489434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
    Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three common CARD15 mutations are not responsible for the pathogenesis of Crohn's disease in Iranians.
    Teimoori-Toolabi L; Vahedi H; Mollahajian H; Kamali E; Hajizadeh-Sikaroodi S; Zeinali S; Tabrizian T; Olfati G; Rashtak S; Malekzadeh F; Ghoddosi A; Malekzadeh R
    Hepatogastroenterology; 2010; 57(98):275-82. PubMed ID: 20583427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis.
    Newman B; Rubin LA; Siminovitch KA
    J Rheumatol; 2003 Feb; 30(2):305-7. PubMed ID: 12563685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.